Abstract
The predictive value of 18F-fluorodeoxyglucose (FDG) PET for conversion from mild cognitive impairment (MCI) to Alzheimer’s dementia (AD) is currently under debate. We used a principal component analysis (PCA) to identify a metabolic AD conversion-related pattern (ADCRP) and investigated the prognostic value of the resulting pattern expression score (PES). Methods: FDG PET scans of 544 MCI patients obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database were analyzed. We implemented voxel-based PCA and standard SPM (as reference) analyses to disclose cerebral metabolic patterns associated with conversion from MCI to AD. By Cox proportional hazards regression we examined the prognostic value of candidate predictors. Also, we constructed prognostic models with: i) clinical, ii) imaging, and iii) clinical and imaging variables in combination. Results: PCA revealed an ADCRP that involved regions with relative decrease in metabolism (temporoparietal, frontal, posterior cingulate and precuneus cortex) and relative increase in metabolism (sensorimotor and occipital cortex, cerebellum and left putamen). Among the predictor variables age, sex, functional activities questionnaire (FAQ), mini-mental state examination (MMSE), apolipoprotein E (APOE), PES and normalized FDG uptake (regions with significant hypo- and hypermetabolism in converters compared to non-converters), PES was the best independent predictor of conversion (Hazard Ratio = 1.77 per z-score increase, 95% C.I.: 1.24 - 2.52, p < 0.001). Moreover, adding PES to the model including the clinical variables significantly increased its prognostic value. Conclusions: The ADCRP expression score is a valid predictor of conversion. Combining clinical variables and PES yielded a higher accuracy than each single tool in predicting conversion of MCI to AD, underlining the incremental utility of FDG PET.

This publication has 31 references indexed in Scilit: